Skip to main content
. 2021 Aug 23;11:17069. doi: 10.1038/s41598-021-96627-7

Figure 4.

Figure 4

K321Q and K353Q tau acetylmimetics inhibit prion-like seeded aggregation in the context of P301L mutation. Cell-based tau inclusion assays were used to determine aggregation and prion-like seeding of (A) 0N4R WT tau, and (B) P301L, (C) K259Q/P301L, (D) K290Q/P301L, (E) K321Q/P301L/, and (F) K353Q/ P301L 0N4R tau. Immunoblots were probed with tau antibody 3026. The relative molecular weight markers are shown on the left. (G) One-way ANOVA with Dunnett’s test was performed with N = 3 for WT tau and all mutations. ****p < 0.0001 and ns not statistically significant.